Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04746131
Title Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.